{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.5043","meta":{"versionId":"5","lastUpdated":"2020-09-14T14:34:23.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Clinical Architecture"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-06-21"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2020-09-14"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.5043","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.3616.200.110.102.5043"}],"version":"20200724","name":"SARSCoronavirus2IgAIgMCombinedQualitative","title":"SARS Coronavirus 2 IgA  IgM Combined, Qualitative","status":"retired","experimental":false,"date":"2023-06-21T18:16:37-04:00","publisher":"Clinical Architecture","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values contains terms related to qualitative detection of IgA and IgM antibodies against SARS coronavirus 2 (SARS-CoV-2). The assays do not distinguish between IgA and IgM antibodies.),(Data Element Scope: ),(Inclusion Criteria: Includes detection of IgA and IgM antibodies against SARS coronavirus 2 (SARS-CoV-2).),(Exclusion Criteria: )","compose":{"include":[{"system":"http://loinc.org","concept":[{"code":"95125-1","display":"SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay"}]}]},"expansion":{"identifier":"urn:uuid:a9fc373a-d70e-4963-abb2-e27f73b59017","timestamp":"2023-12-11T01:42:28-05:00","total":1,"contains":[{"system":"http://loinc.org","version":"2.76","code":"95125-1","display":"SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay"}]}}